Ignite Creation Date:
2025-12-24 @ 10:56 PM
Ignite Modification Date:
2026-01-01 @ 2:26 PM
Study NCT ID:
NCT02536469
Status:
COMPLETED
Last Update Posted:
2017-02-03
First Post:
2015-08-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
HuMax-IL8 (Interleukin8) in Patients With Advanced Malignant Solid Tumors
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-08
Start Date Type:
None
Primary Completion Date:
2016-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-11
Completion Date Type:
ACTUAL
First Submit Date:
2015-08-23
First Submit QC Date:
None
Study First Post Date:
2015-08-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-02-01
Last Update Post Date:
2017-02-03
Last Update Post Date Type:
ESTIMATED